LERIGLITAZONE

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: K824X25AYA

Structure
InChI Key OXVFDZYQLGRLCD-UHFFFAOYSA-N
Smile CC(O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1
InChI
InChI=1S/C19H20N2O4S/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17/h2-7,11-12,17,22H,8-10H2,1H3,(H,21,23,24)

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H20N2O4S
Molecular Weight 372.45
AlogP 2.65
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 7.0
Polar Surface Area 88.52
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 26.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Peroxisome proliferator-activated receptor gamma agonist PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transcription factor Nuclear receptor Nuclear hormone receptor subfamily 1 Nuclear hormone receptor subfamily 1 group C Nuclear hormone receptor subfamily 1 group C member 3
680-2100 13000 708 1200 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Friedreich Ataxia 2 D005621 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 82937
ChEMBL CHEMBL1267
DrugBank DB15021
EPA CompTox DTXSID30399914
FDA SRS K824X25AYA
PubChem 4147757
SureChEMBL SCHEMBL4098326
CONTENTS